GHTM

Global Health and Tropical Medicine

  • GHTM
    • About GHTM
    • Governance
    • Impact
    • Members
    • Scientific Advisory Board
    • Reports
      • GHTM
  • Research
    • Cross-cutting issues
      • Genomic Surveillance and Population Mobility
      • Antimicrobial Resistance and Drug Discovery
      • Host–Pathogen Interactions
      • Information for Health Development
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • PRIME – Pathogen resistance, infection and molecular epidemiology
      • VBD – Vector borne diseases
      • CTM – Clinical tropical medicine
    • Research in numbers
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
      • Completed Projects
  • Outreach
    • Events
    • News
    • Policy Support & Community Outreach
  • Publications
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Capacity Building
    • Education
      • Master Theses
      • PhD Theses
    • International
  • Infrastructures
    • BIOHUB & Available Software
    • BIOTROP Biobank
    • VIASEF & Insectaries
  • Networks & Partnerships
Home / Research / Cross-cutting issues / Host–Pathogen Interactions

Host–Pathogen Interactions

Investigate how host, pathogen, and environmental factors interact to influence infection, disease progression, and resistance, ultimately supporting the development of evidence-based interventions. such as vaccines, new therapeutics, and infection-blocking strategies.

It will strengthen collaboration among the research groups by integrating molecular, clinical, and population-level approaches to infectious disease research.

HPI will bridge laboratory-based discoveries with clinical and public health applications, ensuring that mechanistic insights from PRIME and VBD are translated into transmission control tools, patient care and health policy through CTM and PPS, in alignment with GHTM’s OH and GH missions.

HPI will establish shared data and sample pipelines linking laboratory, vector, and clinical cohorts, supported by infrastructures such as VIASEF, BIOTROP, and the Bioinformatics Hub.

Projects will address host-associated protection mechanisms, immunopathogenesis and disease severity,microbial virulence and drug resistance mechanisms, vector competence, microbiome interactions, and environmental determinants of transmission. Cutting-edge methodology, molecular and cellular biology, omics, spatial modeling, and AI-assisted analysis will be employed to generate joint outputs such as biomarker discovery, molecular signatures for early diagnosis, and candidate molecules for transmission blocking or drug development.

Findings will integrate into CTM-led clinical protocols and PPS-led implementation studies, promoting feasible and equitable disease control solutions, particularly in PALOP and other endemic regions. Joint training programs and advanced methodological workshops will foster capacity building and sustained interdisciplinary collaboration (eg. MulhereSTrop).

Recent Highlights

Jornadas GHTM 2026 Debates the Future of Global Health Through the Lens of One Health and Mobility

Posted: 2026-05-15

Experts and health professionals gathered at IHMT NOVA to discuss One Health, mobility, AI, climate change, and Global Health challenges.
Read More

Posts not found

Facilitator

Ana Paula Arez

Ana Paula Arez

 

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Pinterest (Opens in new window) Pinterest
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Print (Opens in new window) Print

About GHTM

GHTM is a R&D Unit that brings together researchers with a track record in Tropical Medicine and International & Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal

+351 213 652 600

  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Funding

UID/04413/2025 - DOI: 10.54499/UID/04413/2025

UID/PRR/04413/2025 - DOI: 10.54499/UID/PRR/04413/2025

UID/PRR2/04413/2025 - DOI: 10.54499/UID/PRR2/04413/2025

  • Events
  • Research Groups
  • Cross-cutting issues
© Copyright 2026 IHMT-UNL All Rights Reserved.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    UIDB/04413/2020
    UIDP/04413/2020

Loading Comments...

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.